Document Detail

Riociguat as a treatment regime for pulmonary arterial hypertension: a review.
MedLine Citation:
PMID:  25268409     Owner:  NLM     Status:  Publisher    
Abstract Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) is a life-threatening condition distinguished by elevated pressure of pulmonary arteries and increased vascular resistance. The management of patients with PAH and CTEPH has advanced rapidly over last decade but despite the progress in the treatment, the survival of suffering patients remain unsatisfactory and there is no cure for the diseases. However, surgery is not a first choice for patients. Furthermore, some patients who undergo surgery have persistent pulmonary hypertension (HTN) as a side effect after surgery. Therefore, the search for an "ideal" therapy still goes on and it lead to the approval of riociguat as a potential agent for the treatment. It acts directly on soluble guanylate cyclase, exciting the enzyme, and elevating sensitivity to lower levels of NO. Riociguat, therefore, has potential as a novel therapy for PAH and CTEPH. This review is focused on various aspects of the recently approved "riociguat" including its efficacy and safety profiles with the clinical data highlighting its importance in the present scenario.
Bawneet K Narang; Subhajit Roy; Rajiv Sharma; Virender Singh; Ravindra K Rawal
Related Documents :
7055429 - Isolated atherosclerotic aneurysms of the internal iliac arteries: report of two cases ...
19669689 - Incidence and risk factors for multiple intracranial saccular aneurysms in patients wit...
10697229 - Elective neck clipping for unruptured aneurysms in elderly patients.
16924509 - First report of an unusual, rare complication of pregnancy: rupture of multiple lienal ...
9445349 - Apoptosis of medial smooth muscle cells in the development of saccular cerebral aneurys...
17457019 - Ruptured aneurysm of the distal anterior cerebral artery: clinical features and surgica...
22071929 - Direct vascular control results in less physiologic derangement than proximal aortic cl...
25390509 - Takayasu retinopathy presenting as amaurosis fugax in a young patient.
17083119 - In vivo mr imaging of pulmonary arteries of normal and experimental emboli in small ani...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-9-30
Journal Detail:
Title:  Clinical and experimental hypertension (New York, N.Y. : 1993)     Volume:  -     ISSN:  1525-6006     ISO Abbreviation:  Clin. Exp. Hypertens.     Publication Date:  2014 Sep 
Date Detail:
Created Date:  2014-9-30     Completed Date:  -     Revised Date:  2014-10-1    
Medline Journal Info:
Nlm Unique ID:  9305929     Medline TA:  Clin Exp Hypertens     Country:  -    
Other Details:
Languages:  ENG     Pagination:  1-9     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effects of hormone therapy on blood pressure.
Next Document:  The national ambulatory medical care survey: 1973 summary United States, may 1973-april 1974.